Mounjaro

Mounjaro (generic name: tirzepatide) is an injectable prescription medicine that is used to treat adults with type 2 diabetes . It i s prescribed along with diet and exercise to improve control of blood sugar levels. Mounjaro is widely used thanks to its efficacy and safety as a single therapy or with other diabetes medicines. Tirzepatide (GIP/GLP-1RA) is a single molecule combining glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1RA). It activates the secretion of GIP and GLP-1 receptors from the intestines on ingestion of glucose or nutrients, which in turn stimulates insulin secretion from pancreatic β cells.  It also is active in regions of the brain that regulate food intake. Tirzepatide slows down the emptying of the stomach after eating, leaving people feeling full for longer and suppressing appetite. Mounjaro is not for use in people with type 1 diabetes. While there is no cure for diabetes, it was found in studies of Mounjaro that after 52 weeks,  when administered both with or without other diabetes medications, 75% to 90% of patients with an average starting HbA1C of 7.9% to 8.6% reached an HbA1C of less than 7%. Mounjaro is also effective to help with body weight reduction and was approved by the FDA for this putpose in November 2023.  In studies, weight loss in adults ranged from 12 lb (5 kg) to 25 lb (10 kg). The results in studies where candidates received tirzepatide surpass trials of other GLP-1 agonists.
Mounjaro can be prescribed for patients classified as overweight (BMI of 27 – 29.9 with at least one weight-related comorbid condition, such as dyslipidemia, hypertension, obstructive sleep apnea, or cardiovascular disease) or obese (BMI greater than 30) Dosage Mounjaro comes in single-dose vials with syringes for subcutaneous injection. It should be administered once each week on the same day of the week and at approximately the same time of day . It must injected in rotation in either the abdomen, thigh, or upper arm by choosing a different site each week. If a dose is missed, it can be made up for within three days, but beyond that, the dose must be skipped and the routine dose taken on the due date. Do not take two doses of Mounjaro within 72 hours of each other and if it is necessary to change the day, make sure there are at least 72 hours in between doses. If taking insulin and Mounjaro simultaneously, do not inject them close together in the same area. Carefully read the information and follow instructions on the manufacturer Eli Lilly and Company’s Product Insert leaflet that comes with the medication to ensure safe usage. Watch a step-by-step video on how to use Mounjaro. We cannot be held liable for any harm caused by incorrect usage.